Dsm Capital Partners Has Decreased Its Norwegian Cruise Line (NCLH) Holding; Sabby Management Has Lowered Proqr Therapeutics N V (PRQR) Position By $525,255

June 23, 2018 - By Michael Collier

Norwegian Cruise Line Holdings Ltd. (NASDAQ:NCLH) Logo

Dsm Capital Partners Llc decreased Norwegian Cruise Line (NCLH) stake by 0.83% reported in 2018Q1 SEC filing. Dsm Capital Partners Llc sold 32,316 shares as Norwegian Cruise Line (NCLH)’s stock declined 6.59%. The Dsm Capital Partners Llc holds 3.85 million shares with $204.14M value, down from 3.89 million last quarter. Norwegian Cruise Line now has $11.68 billion valuation. The stock increased 0.12% or $0.06 during the last trading session, reaching $51.96. About 3.33 million shares traded or 71.26% up from the average. Norwegian Cruise Line Holdings Ltd. (NASDAQ:NCLH) has risen 6.81% since June 23, 2017 and is uptrending. It has underperformed by 5.76% the S&P500. Some Historical NCLH News: 24/05/2018 – Hawaii helicopter evacuation readied as new lava stream hits ocean; 18/04/2018 – Norwegian Cruise Line Holdings Ltd. Announces $1 Billion Share Repurchase Program; 24/04/2018 – Norwegian Cruise Line Holdings Appoints Pamela Thomas-Graham to Board; 02/05/2018 – Norwegian Cruise Line New $1 B, Three-Yr Shr Repurchase Program Authorization Announced; 24/04/2018 – Norwegian Cruise Line Holdings Appoints Pamela Thomas-Graham to Its Board of Directors; 04/05/2018 – Norwegian Cruise Line Partners With DeCurtis Corporation To Develop – Cruise Freedom™ – A State-of-the-Art Technology Platform; 02/05/2018 – Norwegian Cruise Line Load Factor and Pricing Continuing to Be Well Ahead of Prior Yr for the Remaining Quarters of 2018 and Throughout 2019; 02/05/2018 – NORWEGIAN CRUISE 1Q ADJ EPS 60C, EST. 54C; 14/05/2018 – Morgan Stanley Intl Adds Norwegian Cruise, Cuts Cigna: 13F; 18/04/2018 – NORWEGIAN CRUISE BOARD APPROVES 3-YEAR, $1B SHARE BUYBACK PLAN

Sabby Management Llc decreased Proqr Therapeutics N V (PRQR) stake by 50.42% reported in 2018Q1 SEC filing. Sabby Management Llc sold 175,085 shares as Proqr Therapeutics N V (PRQR)’s stock rose 73.53%. The Sabby Management Llc holds 172,160 shares with $529,000 value, down from 347,245 last quarter. Proqr Therapeutics N V now has $228.24 million valuation. The stock increased 1.42% or $0.1 during the last trading session, reaching $7.15. About 41,832 shares traded. ProQR Therapeutics N.V. (NASDAQ:PRQR) has risen 19.19% since June 23, 2017 and is uptrending. It has outperformed by 6.62% the S&P500. Some Historical PRQR News: 11/04/2018 – ProQR Announces Annual Meeting of Shareholders; 23/04/2018 – ProQR Therapeutics Access Event Scheduled By LifeSci Advisors; 23/05/2018 – PROQR APPOINTS Yl-TAO YU, PH.D., TO ITS SCIENTIFIC ADVISORY BOARD; 10/04/2018 – ProQR Appoints ADAR Expert Dr. Peter A. Beal to Scientific Advisory Board to Focus on Axiomer® RNA A-to-l Editing Technology; 25/05/2018 – ADAGE CAPITAL PARTNERS REPORTS 5.88 PCT PASSIVE STAKE IN PROQR THERAPEUTICS NV AS OF MAY 17 – SEC FILING; 09/05/2018 – PROQR THERAPEUTICS NV – AT MARCH 31, 2018, PROQR HELD CASH AND CASH EQUIVALENTS OF €38.0 MILLION, COMPARED TO €48.1 MILLION AT DECEMBER 31, 2017; 09/04/2018 ProQR Therapeutics Conference Call Set By Chardan for Apr. 12; 30/04/2018 – ProQR Announces Conference Presentations for Axiomer® RNA Editing Technology and QR-313 for DEB; 10/04/2018 – ProQR Appoints ADAR Expert Dr. Peter A. Beal to Scientific Advisory Board to Focus on Axiomer® RNA A-to-I Editing Technology; 23/05/2018 – ProQR Appoints Yi-Tao Yu, Ph.D., to Its Scientific Advisory Board

Sabby Management Llc increased Incyte Corp (Call) stake by 608 shares to 1,140 valued at $9.50 million in 2018Q1. It also upped Astrazeneca Plc (Put) stake by 869 shares and now owns 8,380 shares. Esperion Therapeutics Inc (Call) was raised too.

Among 5 analysts covering ProQR Therapeutics N.V. (NASDAQ:PRQR), 4 have Buy rating, 0 Sell and 1 Hold. Therefore 80% are positive. ProQR Therapeutics N.V. had 8 analyst reports since March 15, 2016 according to SRatingsIntel. Chardan Capital Markets initiated the shares of PRQR in report on Monday, June 20 with “Neutral” rating. H.C. Wainwright maintained the stock with “Buy” rating in Tuesday, June 20 report. The stock of ProQR Therapeutics N.V. (NASDAQ:PRQR) has “Buy” rating given on Thursday, March 1 by H.C. Wainwright. As per Thursday, September 29, the company rating was initiated by Janney Capital. The stock of ProQR Therapeutics N.V. (NASDAQ:PRQR) earned “Outperform” rating by Leerink Swann on Tuesday, September 26. The firm has “Market Outperform” rating given on Tuesday, March 15 by JMP Securities.

More important recent ProQR Therapeutics N.V. (NASDAQ:PRQR) news were published by: Globenewswire.com which released: “ProQR to Present at the JMP Life Sciences Conference” on June 14, 2018, also Seekingalpha.com published article titled: “ProQR inks deal with EBRP and EBMRF to develop QR-313 for the treatment of DEB”, Nasdaq.com published: “ProQR Receives up to $5 Million in Partnership with EB Research Partnership and EB Medical Research Foundation to …” on June 12, 2018. More interesting news about ProQR Therapeutics N.V. (NASDAQ:PRQR) was released by: Benzinga.com and their article: “44 Biggest Movers From Yesterday” with publication date: June 05, 2018.

More news for Norwegian Cruise Line Holdings Ltd. (NASDAQ:NCLH) were recently published by: Seekingalpha.com, which released: “Norwegian Cruise Line: Time To Buy” on June 15, 2018. Streetinsider.com‘s article titled: “Norwegian Cruise Line Holdings (NCLH) PT Raised to $72 at Nomura/Instinet” and published on June 13, 2018 is yet another important article.

Investors sentiment increased to 1.67 in 2018 Q1. Its up 0.33, from 1.34 in 2017Q4. It is positive, as 38 investors sold NCLH shares while 91 reduced holdings. 61 funds opened positions while 154 raised stakes. 208.22 million shares or 2.74% more from 202.66 million shares in 2017Q4 were reported. Arizona State Retirement System invested in 95,792 shares or 0.05% of the stock. Cap Int Invsts, a California-based fund reported 9.06 million shares. Invesco has 0.09% invested in Norwegian Cruise Line Holdings Ltd. (NASDAQ:NCLH). Moreover, Credit Suisse Ag has 0.02% invested in Norwegian Cruise Line Holdings Ltd. (NASDAQ:NCLH) for 373,628 shares. 2.64 million are owned by Bank & Trust Of Ny Mellon. Capital Mngmt Corp Va holds 0.82% or 57,415 shares. Da Davidson And holds 0% or 4,283 shares. State Street stated it has 0.03% of its portfolio in Norwegian Cruise Line Holdings Ltd. (NASDAQ:NCLH). Comml Bank Of The West holds 0.2% in Norwegian Cruise Line Holdings Ltd. (NASDAQ:NCLH) or 30,748 shares. Cambiar Ltd Company holds 0.06% or 73,410 shares. Creative Planning invested 0.02% in Norwegian Cruise Line Holdings Ltd. (NASDAQ:NCLH). Manufacturers Life The owns 211,426 shares or 0.01% of their US portfolio. Tiaa Cref Mngmt Llc stated it has 263,173 shares or 0.01% of all its holdings. Washington Fincl Bank invested in 0.01% or 896 shares. Rampart Investment Mgmt Ltd Company has 16,730 shares for 0.08% of their portfolio.

Since March 2, 2018, it had 0 insider purchases, and 3 insider sales for $1.09 billion activity. On Friday, March 2 the insider Apollo Management Holdings GP – LLC sold $546.00 million. Del Rio Frank J also sold $167,212 worth of Norwegian Cruise Line Holdings Ltd. (NASDAQ:NCLH) on Friday, June 15.

Dsm Capital Partners Llc increased Visa (NYSE:V) stake by 44,636 shares to 3.99 million valued at $477.28M in 2018Q1. It also upped New Oriental Education (NYSE:EDU) stake by 88,955 shares and now owns 583,415 shares. Charles Schwab (NYSE:SCHW) was raised too.

Analysts await Norwegian Cruise Line Holdings Ltd. (NASDAQ:NCLH) to report earnings on August, 14. They expect $1.03 earnings per share, up 13.19% or $0.12 from last year’s $0.91 per share. NCLH’s profit will be $231.43 million for 12.61 P/E if the $1.03 EPS becomes a reality. After $0.60 actual earnings per share reported by Norwegian Cruise Line Holdings Ltd. for the previous quarter, Wall Street now forecasts 71.67% EPS growth.

Among 22 analysts covering Norwegian Cruise Line (NASDAQ:NCLH), 16 have Buy rating, 1 Sell and 5 Hold. Therefore 73% are positive. Norwegian Cruise Line had 60 analyst reports since August 5, 2015 according to SRatingsIntel. As per Thursday, August 3, the company rating was maintained by Stifel Nicolaus. The stock of Norwegian Cruise Line Holdings Ltd. (NASDAQ:NCLH) earned “Buy” rating by Deutsche Bank on Wednesday, April 18. On Thursday, February 22 the stock rating was maintained by Susquehanna with “Buy”. The firm has “Peer Perform” rating by Wolfe Research given on Wednesday, November 18. On Monday, February 5 the stock rating was upgraded by JP Morgan to “Overweight”. The firm earned “Overweight” rating on Wednesday, August 5 by Barclays Capital. The rating was downgraded by Zacks to “Buy” on Monday, August 10. The rating was downgraded by JP Morgan to “Neutral” on Thursday, October 27. The stock has “Neutral” rating by Wedbush on Thursday, February 23. The firm has “Buy” rating given on Tuesday, September 13 by Citigroup.

Norwegian Cruise Line Holdings Ltd. (NASDAQ:NCLH) Ratings Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

>